CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended		77 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
CASH FLOW FROM OPERATING ACTIVITIES
Net loss	$ (2,476,453)	$ (2,150,617)	$ (14,607,738)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization	120,469	145,115	1,097,203
Technology impairment	0	345,000	690,000
Common stock issued for services	0	18,500	318,500
Stock options and warrants	635,603	45,481	3,649,357
(Increase) decrease in assets
Prepaid drug product for testing	46,699	73,500	(148,301)
Other current assets	(7,138)	3,044	(49,713)
Increase (decrease) in liabilities
Accounts payable and accrued expenses	(155,491)	(47,559)	173,753
Net cash used in operating activities	(1,836,311)	(1,567,536)	(8,876,939)
CASH FLOW FROM INVESTING ACTIVITIES
Purchase of exclusive license - related party	0	(25,000)	(884,710)
Net cash used in investing activities	0	(25,000)	(884,710)
CASH FLOW FROM FINANCING ACTIVITIES
Proceeds from convertible notes	0	0	435,000
Cash repayment of convertible notes	0	0	(15,000)
Net proceeds from sale of common stock	5,403,106	973,146	13,442,489
Net cash from financing activities	5,403,106	973,146	13,862,490
NET INCREASE (DECREASE) IN CASH	3,566,795	(619,390)	4,100,841
Cash, beginning of period	534,046	952,252	0
Cash, end of period	4,100,841	332,862	4,100,841
Cash paid for
Interest	0	0	445
Income taxes	0	0	0
Non-cash financing activities
Common stock issued upon conversion of convertible notes	0	0	420,000
Placement Agent
Non-cash financing activities
Common stock issued	448,950	0	1,040,516
MD Anderson for License
Non-cash financing activities
Common stock issued	0	0	2,354,167
LPC
Non-cash financing activities
Common stock issued	$ 0	$ 0	$ 210,755